Nanox Deploys Nanox.ARC Tool at Israeli Medical Center for Study

Nanox Imaging Ltd. and Meir Medical Center are collaborating on a study designed to enhance and expand Nanox.ARC’s clinical evidence.

The trial aims to demonstrate the Nanox.ARC system’s diagnostic value for orthopedic injuries commonly treated in emergency departments, such as accidents and other high-impact incidents. By comparing Nanox.ARC imaging with Meir Medical Center’s existing diagnostic workflow—which typically includes conventional radiography or radiography followed by CT—the study will strive to validate Nanox.ARC’s ability to provide more detailed anatomical information, better diagnostic confidence, and faster clinical decision-making.

“This collaboration with Meir Medical Center advances the ongoing real-world clinical validation of the Nanox.ARC,” Nanox CEO/Acting Chairman Erez Meltzer stated. “Partnerships with institutions like Meir, one of Israel’s largest hospital networks, are essential to building the clinical evidence base that will support broader adoption of our technology. Our long-term goal is to make advanced 3D imaging accessible, cost-efficient, and a standard part of patient care worldwide.”

The Nanox.ARC is a multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings at a lower cost and reduced radiation dose compared to traditional CT. The system is intended to produce tomographic images for general use, including the human musculoskeletal system, pulmonary, intra-abdominal, and paranasal sinus indications, adjunctive to conventional radiography, on adult patients.

“The orthopedic division at Meir Medical Center, under my leadership, is deeply committed to innovation and technological advancement as powerful engines for progress in Israeli healthcare,” said Professor Nissim Ohana, M.D., head of the Orthopedic Division at Meir Medical Center. “We welcome our collaboration with Nanox and hope that evaluating the Nanox.ARC in real-time emergency settings will have the potential to significantly improve fracture detection and to meaningfully benefit our patients.”

In addition to reviewing comparative performance, the study will assess how incorporating Nanox.ARC at the earliest stages of triage may create a more efficient and lower-radiation diagnostic pathway. Nanox.ARC’s multisource technology can potentially offer enhanced visualization of subtle, complex, or overlapping anatomical structures that are not always clearly visible on 2D imaging, while avoiding the higher radiation and resource demands of CT scanning.

The study will be conducted as part of a structured research protocol approved by Meir’s Helsinki Committee (IRB) and is designed to improve the precision, speed, and clinical utility of emergency fracture diagnosis.

Nanox combines affordable imaging hardware, advanced artificial intelligence (AI)-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. Nanox is striving to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early disease detection, and improve patient outcomes.

The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide.

As one of Israel’s largest and most leading medical centers, Meir Medical Center delivers advanced, innovative medical care. Since its founding in 1956, the hospital has grown to serve a regional population of approximately 1 million residents in the Sharon area. The 801-bed facility is staffed by a multidisciplinary team of more than 4,200 professionals—including nearly 1,000 physicians—and manages over 60,000 annual admissions and 190,000 emergency visits. Internationally accredited by JCI, Meir is home to Centers of Excellence in orthopedics, cardiology, and respiratory medicine, and serves as the official medical advisor to the Israeli National Olympic Team, reflecting its leadership in sports medicine and rehabilitation. As an academic medical center affiliated with Tel Aviv University, MMC is engaged in clinical research, medical education, and innovation.